We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-1.57%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$6.49B
AUM Growth
-$396M
Cap. Flow
-$220M
Cap. Flow %
-3.39%
Top 10 Hldgs %
43.16%
Holding
163
New
23
Increased
16
Reduced
43
Closed
16

Top Buys

Rank Stock Value
1
LIAN
LianBio American Depositary Shares
LIAN
+$643M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$97.4M
3
BLU
BELLUS Health Inc.
BLU
+$50.7M
4
ISO
IsoPlexis Corporation Common Stock
ISO
+$45.4M
5
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$33.3M

Top Sells

Rank Stock Value
1
AVIR icon
Atea Pharmaceuticals
AVIR
+$79.2M
2
NVTA
Invitae Corporation
NVTA
+$50.6M
3
BEAM icon
Beam Therapeutics
BEAM
+$46.8M
4
DBVT
DBV Technologies
DBVT
+$37.7M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$30M

Sector Composition

Rank Sector Weight
1 Healthcare 85.98%
2 Miscellaneous 13.04%
3 Financials 0.8%
4 Industrials 0.09%
5 Consumer Staples 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARA icon
126
Protara Therapeutics
TARA
$222M
$2.85M 0.04%
421,641
– –
SRZN icon
127
Surrozen
SRZN
$209M
$2.66M 0.04%
27,563
-5,770
-17% -$654K
YARW
128
Yarrow Bioscience
YARW
$68.1M
$2.22M 0.03%
2,420
-169
-7% -$181K
DCPH
129
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.95M 0.03%
+200,000
New +$3.76M
NVRO
130
DELISTED
NEVRO CORP.
NVRO
$1.86M 0.03%
22,946
-237,026
-91% -$23.8M
RACE icon
131
Ferrari
RACE
$71.5B
$1.6M 0.02%
6,200
– –
ITOS
132
DELISTED
iTeos Therapeutics
ITOS
$931K 0.01%
+20,000
New +$666K
MOTS
133
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$841K 0.01%
6,002
– –
EIGR
134
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$726K 0.01%
4,663
– –
RKLY.WS
135
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
$605K 0.01%
500,000
– –
UTRS
136
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$451K 0.01%
+4,388
New +$624K
PHVS icon
137
Pharvaris
PHVS
$2.67B
$389K 0.01%
27,000
– –
SLGCW
138
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$367K 0.01%
110,000
– –
BFLY.WS
139
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$296K ﹤0.01%
233,333
– –
EQRXW
140
DELISTED
EQRx, Inc. Warrant
EQRXW
$266K ﹤0.01%
+250,000
New +$458K
SRZNW
141
DELISTED
Surrozen Inc Warrant
SRZNW
$192K ﹤0.01%
166,666
– –
CMAXW
142
DELISTED
CareMax, Inc. Warrant
CMAXW
$84K ﹤0.01%
60,000
– –
ATEC icon
143
Alphatec Holdings
ATEC
$1.65B
– –
-430,900
Closed -$5.25M
AVIR icon
144
Atea Pharmaceuticals
AVIR
$419M
– –
-2,259,224
Closed -$79.2M
BEAM icon
145
Beam Therapeutics
BEAM
$2.4B
– –
-537,635
Closed -$46.8M
DBVT
146
DBV Technologies
DBVT
$739M
– –
-769,551
Closed -$37.7M
FDMT icon
147
4D Molecular Therapeutics
FDMT
$753M
– –
-375,256
Closed -$10.1M
KRRO icon
148
Korro Bio
KRRO
$207M
– –
-4,444
Closed -$1.57M
NTRA icon
149
Natera
NTRA
$50.6B
– –
-160,000
Closed -$17.8M
PODD icon
150
Insulet
PODD
$9.66B
– –
-44,522
Closed -$12.7M
3 4 5
6
7

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Perceptive Advisors held 163 positions worth $6.49B, down 5.7% from $6.88B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Perceptive Advisors withdrew a net $220M in Q4 2021, closing 16 positions and reducing 43 holdings. Its most notable exit was Atea Pharmaceuticals, an estimated $79.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 86% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, Perceptive Advisors opened a new position in LianBio American Depositary Shares worth $347M.

  • Perceptive Advisors's largest Q4 2021 buy was LianBio American Depositary Shares: 56,319,960 shares worth $347M.
  • Perceptive Advisors added most to Apellis Pharmaceuticals in Q4 2021, an estimated $32.9M increase.
  • Perceptive Advisors's biggest Q4 2021 reduction was Invitae Corporation, cutting an estimated $50.6M.
  • Perceptive Advisors fully exited Atea Pharmaceuticals in Q4 2021, selling an estimated $79.2M.
  • Perceptive Advisors's ten largest holdings make up 43% of its $6.49B portfolio in Q4 2021.
  • Perceptive Advisors opened 23 new positions and closed 16 in Q4 2021.
  • Perceptive Advisors's portfolio value fell 5.7% quarter-over-quarter to $6.49B.

Based on Perceptive Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.